LPAR2 and prostate carcinoma: In our study, ATX and LPA1 expression was a poor prognosis factor in PTC, which is in concordance with previous study results that had identified ATX as a poor prognosis factor in breast cancer [19] and in prostate cancer [20] and, separately, LPA2 as a poor prognosis factor in breast cancer [21].